Ripertamab
mAbexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started May 1, 2015 (NCT02456207)
Timeline
Indications
Mechanism of action
MS4A1 adcc
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594604 ↗
Also known as
- sct400
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06405100 | Phase 3 | May 31, 2024 | Air Force Military Medical University, China, Jiao Tong University, Shaanxi Provincial People's Hospital |
| NCT02772822 | Phase 3 | Jun 1, 2016 | Sinocelltech Ltd. |
| NCT02456207 | Phase 2 | May 1, 2015 | Sinocelltech Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sinocelltech Ltd. | For profit | 2 | 2 | 2 | 2015 |
| Air Force Military Medical University, China | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Shaanxi Provincial People's Hospital | Academic/Hospital | 1 | 0 | 1 | 2024 |
4 organizations
Page 1 / 1